Bill > A5588

This bill requires prescription drug services covered under the Medicaid program in New Jersey to be provided via a fee-for-service delivery system. The bill outlines the reimbursement methodology for covered outpatient brand name and generic drugs, as well as covered outpatient specialty drugs dispensed by mail order pharmacies and covered entities under the 340B program. The bill also mandates that clotting factors be billed through a Point of Sale System as of January 1, 2020. The Commissioner of Human Services is directed to apply for any necessary state plan amendments or waivers to implement the provisions of the bill and secure federal financial participation, and to adopt rules and regulations to effectuate the purposes of the act.

Health and Social Services

https://www.njleg.state.nj.us/bill-search/2022/A5588